Biosimilars: The strategic leap in clinical research and access to biological therapies
Over the past two decades, biological medicines have transformed the treatment of chronic and complex diseases such as cancer, rheumatoid arthritis, and diabetes. However, the high cost of these therapies has limited access for millions of patients worldwide, placing pressure on public and private healthcare systems. In this context, biosimilars – medicines that are […]